Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Blood Cancer J
.
2024 Jan 25;14(1):22.
doi: 10.1038/s41408-023-00940-5.
Authors
Thomas Roberts
1
,
Grace Uwenedi
1
,
Rachel Bruton
1
,
Graham McIlroy
1
2
,
Sarah Damery
3
,
Panagiota Sylla
1
,
Nicola Logan
4
,
Sam Scott
4
,
May Lau
1
,
Ahmed Elzaidi
1
,
Siobhan Plass
1
,
Soumyajit Mallick
1
,
Katie Spencer
1
,
Christine Stephens
1
,
Christopher Bentley
1
,
Guy Pratt
2
,
Jianmin Zuo
1
,
Shankara Paneesha
2
,
Brian Willett
4
,
Paul Moss
1
2
,
Helen Parry
5
6
Affiliations
1
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
2
University Hospitals Birmingham, Edgbaston, Birmingham, B15 2GW, UK.
3
Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
4
MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, G61 1QH, UK.
5
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
[email protected]
.
6
University Hospitals Birmingham, Edgbaston, Birmingham, B15 2GW, UK.
[email protected]
.
PMID:
38272915
PMCID:
PMC10810811
DOI:
10.1038/s41408-023-00940-5
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19* / prevention & control
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Grants and funding
MC_PC_20031/MRC_/Medical Research Council/United Kingdom
MC_PC_20060/MRC_/Medical Research Council/United Kingdom
MR/X006891/1/MRC_/Medical Research Council/United Kingdom